MANNKIND CORP 8K

MannKind Corporation agreed to register $50 million of newly issued common stock and pre-funded warrant shares for resale by investors under a detailed Registration Rights Agreement with timing, blackout, cutback, and liquidated-damages protections.

On July 23, 2026, MannKind Corporation entered into a Registration Rights Agreement with certain investors in connection with their purchase of $50 million of MannKind common stock and/or pre-funded warrants, granting the investors demand-style resale registration rights for all underlying shares, obligating MannKind to file and maintain one or more SEC registration statements on a specified timetable, keep them effective for a defined registration period, list the shares on Nasdaq, and provide customary indemnification, while agreeing to pay liquidated damages (capped at 5% of the investors’ purchase price) if it fails to meet key filing or effectiveness deadlines or maintain usable registration, subject to limited blackout and SEC-related cutback provisions.

Filing Facts

CIK

899460

Ticker

MNKD

Form

8K

Source Type

fda

Accession

0001193125-26-316041

Alert Tier

6